Insights

Cutting-edge cancer treatment technology SkinCure Oncology offers GentleCure™, an advanced nonsurgical treatment for skin cancers using Image-Guided SRT technology. The use of Sensus SRT-100 Vision™ provides high-frequency ultrasound imaging, delivering precise doses of X-ray energy that destroy cancer cells while preserving healthy tissue. This cutting-edge technology presents a compelling selling point for practices looking to enhance their cancer treatment offerings.

Strategic partnership opportunities SkinCure Oncology collaborates with dermatologists and Mohs surgeons to bring cancer center-level radiation therapy to physician offices. This partnership model opens up opportunities for cross-promotion and joint marketing efforts, allowing for the expansion of services and patient reach. Leveraging these strategic partnerships can lead to increased market penetration and revenue growth.

Competitive advantage in the oncology market With a focus on delivering comprehensive skin cancer treatment, SkinCure Oncology positions itself as a leader in the oncology market. The unique offering of GentleCure™ and the exclusive use of Image-Guided SRT technology sets the company apart from competitors. Highlighting this competitive advantage during sales pitches can help in attracting healthcare providers seeking innovative solutions for skin cancer treatment.

Strong financial backing and stability SkinCure Oncology's healthy financial status, with revenue in the range of $100M - 1B and funding of $31M, signifies stability and growth potential. This financial backing not only instills confidence in potential clients but also demonstrates the company's capacity for continued innovation and service expansion. Emphasizing the company's financial strength can be pivotal in building trust with prospective partners and clients.

Opportunities for market expansion and diversification Given SkinCure Oncology's focus on technological advancements and partnership-driven approach, there are opportunities for market expansion and diversification. Targeting regions where there is a demand for advanced skin cancer treatments or exploring new collaborations with healthcare providers can facilitate business growth. Identifying and pursuing these expansion avenues can lead to increased sales and market presence.

SkinCure Oncology Tech Stack

SkinCure Oncology uses 8 technology products and services including Twitter Emoji (Twemoji), Adobe Fonts, Google Cloud, and more. Explore SkinCure Oncology's tech stack below.

  • Twitter Emoji (Twemoji)
    Font Scripts
  • Adobe Fonts
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • Slick
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Priority Hints
    Performance
  • Yoast SEO
    Search Engines
  • Wistia
    Video Players

Media & News

SkinCure Oncology's Email Address Formats

SkinCure Oncology uses at least 1 format(s):
SkinCure Oncology Email FormatsExamplePercentage
FLast@skincureoncology.comJDoe@skincureoncology.com
49%
First.Last@skincureoncology.comJohn.Doe@skincureoncology.com
1%
FLast@skincureoncology.comJDoe@skincureoncology.com
49%
First.Last@skincureoncology.comJohn.Doe@skincureoncology.com
1%

Frequently Asked Questions

Where is SkinCure Oncology's headquarters located?

Minus sign iconPlus sign icon
SkinCure Oncology's main headquarters is located at 200 S. Frontage Rd. Suite 200 Burr Ridge, IL 60527 US. The company has employees across 3 continents, including North AmericaAfricaAsia.

What is SkinCure Oncology's official website and social media links?

Minus sign iconPlus sign icon
SkinCure Oncology's official website is skincureoncology.com and has social profiles on LinkedIn.

How much revenue does SkinCure Oncology generate?

Minus sign iconPlus sign icon
As of October 2024, SkinCure Oncology's annual revenue reached $750M.

What is SkinCure Oncology's NAICS code?

Minus sign iconPlus sign icon
SkinCure Oncology's NAICS code is 62 - Health Care and Social Assistance.

How many employees does SkinCure Oncology have currently?

Minus sign iconPlus sign icon
As of October 2024, SkinCure Oncology has approximately 501 employees across 3 continents, including North AmericaAfricaAsia. Key team members include Chief Executive Officer, Manager And Co-Founder: K. B.Chief Executive Officer: R. M.Chief Operating Officer: J. S.. Explore SkinCure Oncology's employee directory with LeadIQ.

What industry does SkinCure Oncology belong to?

Minus sign iconPlus sign icon
SkinCure Oncology operates in the Hospitals and Health Care industry.

What technology does SkinCure Oncology use?

Minus sign iconPlus sign icon
SkinCure Oncology's tech stack includes Twitter Emoji (Twemoji)Adobe FontsGoogle CloudSlickOpen GraphPriority HintsYoast SEOWistia.

What is SkinCure Oncology's email format?

Minus sign iconPlus sign icon
SkinCure Oncology's email format typically follows the pattern of . Find more SkinCure Oncology email formats with LeadIQ.

How much funding has SkinCure Oncology raised to date?

Minus sign iconPlus sign icon
As of October 2024, SkinCure Oncology has raised $31M in funding. The last funding round occurred on Sep 24, 2019 for $30M.

When was SkinCure Oncology founded?

Minus sign iconPlus sign icon
SkinCure Oncology was founded in 2016.
SkinCure Oncology

SkinCure Oncology

Hospitals and Health CareIllinois, United States501-1000 Employees

SkinCure Oncology is the only company offering GentleCure™—the most comprehensive approach to delivering advanced, nonsurgical treatment for basal cell carcinoma, squamous cell carcinoma, and other skin cancers using Image-Guided SRT.

The company partners with quality-focused dermatologists and Mohs surgeons to bring cancer center-level radiation therapy to physician offices. From clinical, administrative, and operational backing to robust patient support, SkinCure Oncology ensures that practices are fully equipped to offer treatment with Image-Guided SRT. This advanced technology delivers calibrated doses of X-ray energy via the Sensus SRT-100 Vision™, the first and only skin cancer treatment platform with high-frequency ultrasound imaging. Adaptive radiotherapy protocols destroy malignant cancer cells while preserving healthy tissue surrounding the treated areas for optimal clinical and cosmetic outcomes and the ideal patient experience.

Section iconCompany Overview

Headquarters
200 S. Frontage Rd. Suite 200 Burr Ridge, IL 60527 US
NAICS Code
62 - Health Care and Social Assistance
Founded
2016
Employees
501-1000

Section iconMedia & News

Section iconFunding & Financials

  • $31M

    SkinCure Oncology has raised a total of $31M of funding over 2 rounds. Their latest funding round was raised on Sep 24, 2019 in the amount of $30Mas a growth equity investment.

  • $100M$1B

    SkinCure Oncology's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $31M

    SkinCure Oncology has raised a total of $31M of funding over 2 rounds. Their latest funding round was raised on Sep 24, 2019 in the amount of $30Mas a growth equity investment.

  • $100M$1B

    SkinCure Oncology's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.